Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-019955
Filing Date
2018-07-17
Accepted
2018-07-17 16:44:28
Documents
1
Period of Report
2018-07-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5598
  Complete submission text file 0000899243-18-019955.txt   6981
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Issuer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VICURON PHARMACEUTICALS INC 455 S GULPH ROAD SUITE 305 KING OF PRUSSIA PA 19406
Business Address
DUNTON ALAN W (Reporting) CIK: 0001304773 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32188 | Film No.: 18956882